Evidence map›Paper›PMID 36424361›Full record

ArticleCancer science2023

Influences of intratumoral heterogeneity on assessment of tumor microenvironment in esophageal squamous cell carcinoma.

Kotaro Sugawara, Takashi Fukuda, Yutaka Kishimoto, Daiji Oka, Takako Yoshii, Hiroki Hara, Yukari Uemura, Yoshiyuki Kawashima, Hiroaki Kanda, Noriko Motoi

Open access · goldAbstract read
In one paragraph

Article in Cancer science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Kotaro SugawaraDepartment of Gastroenterological Surgery, Saitama Cancer Center, Saitama, Japan.ORCID https://orcid.org/0000-0002-3272-1748
Takashi FukudaDepartment of Gastroenterological Surgery, Saitama Cancer Center, Saitama, Japan.
Yutaka KishimotoDepartment of Gastroenterological Surgery, Saitama Cancer Center, Saitama, Japan.
Daiji OkaDepartment of Gastroenterological Surgery, Saitama Cancer Center, Saitama, Japan.
Takako YoshiiDepartment of Gastroenterology, Saitama Cancer Center, Saitama, Japan.
Hiroki HaraDepartment of Gastroenterology, Saitama Cancer Center, Saitama, Japan.
Yukari UemuraBiostatistics Section, Department of Data Science, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
Yoshiyuki KawashimaDepartment of Gastroenterological Surgery, Saitama Cancer Center, Saitama, Japan.
Hiroaki KandaDepartment of Pathology, Saitama Cancer Center, Saitama, Japan.
Noriko MotoiDepartment of Pathology, Saitama Cancer Center, Saitama, Japan.ORCID https://orcid.org/0000-0001-7098-3311
Saitama Cancer Center · JPNational Center for Global Health and Medicine · JP

Funding

MEXT KAKENHI 18K07036MEXT KAKENHI 21K06900
6 · The paper itself

Abstract

The intratumoral heterogeneity (ITH) of the tumor microenvironment (TME) has yet to be addressed in esophageal squamous cell carcinoma (ESCC). Here, we studied the ITH of CD8 and PD-L1 status in ESCC, and examined the potential of the tumor surface for representing the TME. In total, 67 surgically resected clinical Stage II ESCC specimens were analyzed. The CD8-cell density, PD-L1 tumor proportion score (TPS), and combined positive score (CPS) were calculated in three (superficial, middle, and deep) areas of each specimen. ITH was quantified by distance-standardized coefficient variations of the three values. The CD8 and PD-L1 status of each area was dichotomized and tumor-surface capabilities for predicting the entire tumor status were estimated. Variables were compared according to the presence of neoadjuvant chemotherapy (NAC). The ITH, especially PD-L1 heterogeneity, differed markedly among specimens. The concordance rates of CD8 and PD-L1 (CPS and TPS) status among the three different areas were 71.6%, 74.6%, and 73.1%, respectively. The sensitivity and the specificity of the tumor surface for predicting the CD8 status of the whole tumor were high, especially in the NAC- group (both 1.0). The tumor surface also showed high capabilities for representing the whole PD-L1 status, while yielding moderate positive predictive values (0.70). The ITH degrees and predictive capabilities did not differ according to NAC. Taken together, the ITH of CD8 and PD-L1 differed among ESCC specimens, while not being markedly affected by NAC. The use of a biopsy specimen from the tumor surface might be feasible for TME evaluation.

Indexed as

Esophageal NeoplasmsEsophageal Squamous Cell CarcinomaB7-H1 AntigenCD8-Positive T-LymphocytesHumansTumor MicroenvironmentB7-H1 Antigenesophageal squamous cell carcinomaintratumoral heterogeneityneoadjuvant chemotherapysurgerytumor microenvironment

Identifiers

PMID36424361
PMCPMC9986096
OpenAlexW4309911443

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.